Expression of micro RNA-9 in Patients with Acute Myeloid Leukemia and its Impact on Treatment Strategy
Mysra Sami Youssef;
Abstract
AML is a malignant disorder of hematopoietic tissue.
It is one of the most common malignancies in adults. It is
characterized by its heterogeneous and complex nature that
includes chromosomal, genetic and epigenetic
abnormalities. MicroRNAs have been described to be one
of the epigenetic regulators in AML.
The present study focused on measuring expression
levels of miR-9 in de novo AML patients.30 bone marrow
samples were collected from patients attending at
hematology and oncology unit of Aldemerdash hospitals.
MiR-9 expression levels were measured using real time
PCR. These expression levels were compared to 30 adult
healthy volunteers.
It is one of the most common malignancies in adults. It is
characterized by its heterogeneous and complex nature that
includes chromosomal, genetic and epigenetic
abnormalities. MicroRNAs have been described to be one
of the epigenetic regulators in AML.
The present study focused on measuring expression
levels of miR-9 in de novo AML patients.30 bone marrow
samples were collected from patients attending at
hematology and oncology unit of Aldemerdash hospitals.
MiR-9 expression levels were measured using real time
PCR. These expression levels were compared to 30 adult
healthy volunteers.
Other data
| Title | Expression of micro RNA-9 in Patients with Acute Myeloid Leukemia and its Impact on Treatment Strategy | Other Titles | نمط الحامض النووي الريبوزي الدقيق 9 في مرضى سرطان الدم النخاعي الحاد وتأثيره على استراتيجية العلاج | Authors | Mysra Sami Youssef | Issue Date | 2018 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.